Zobrazeno 1 - 5
of 5
pro vyhledávání: '"W H, Krüger"'
Autor:
W H Krüger, Manuela Badoglio, Luca Castagna, Pierre Rohrlich, Gerhard Ehninger, Patrick Lutz, Maura Faraci, Uwe Thiel, Peter Bader, C Peters, A. Prete, A. Santucci, A. Salmon, Thomas G. P. Grunewald, Catherine Paillard, P. Schneider, Petar Antunovic, Jan Styczyński, E. Koscielniak, Marie Ouachée-Chardin, B. Gruhn, Franca Fagioli, Franziska Blaeschke, Stefan Burdach, Peter Lang, Miguel Angel Diaz, M. Bregni, Marek Ussowicz
Publikováno v:
British Journal of Cancer
Background: Allogeneic haematopoietic stem cell transplantation (allo-SCT) may provide donor cytotoxic T cell-/NK cell-mediated disease control in patients with rhabdomyosarcoma (RMS). However, little is known about the prevalence of graft-vs-RMS eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40a4d7e204bd04105d524ba93f522f72
http://hdl.handle.net/2318/1690557
http://hdl.handle.net/2318/1690557
Autor:
M. Pulz, W. H. Krüger
Publikováno v:
Journal of Medical Microbiology. 35:98-102
Summary. The polymerase chain reaction (PCR) was used to amplify specific DNA sequences from different clinical isolates of Borrelia burgdorferi and from cerebrospinal fluid (CSF) of two patients with Lyme disease of the central nervous system. The a
Publikováno v:
Bone marrow transplantation. 22
115 patients undergoing allogeneic or autologous bone marrow or peripheral blood stem cell transplantation were treated empirically or for documented fungal infection with liposomal amphotericin-B in doses up to 10mg/kg bodyweight for a duration up t
Autor:
W H, Krüger, M, Stockschläder, S, Hennings, M, Aschenbrenner, M, Gruber, K, Gutensohn, C, Löliger, F, Gieseking, W, Jonat, A R, Zander
Publikováno v:
Bone marrow transplantation. 18
The benefit of high-dose therapy and blood stem cell reinfusion for women with high-risk breast cancer is currently under investigation. Contaminations of autologous blood stem cells with cancer cells have been described. Cancer micrometastases may b
Autor:
W H, Krüger, C, Berger, K B, Mross, P, Bewermeier, U, Pichlmeier, M, Stockschläder, B, Schleimer, A R, Zander
Publikováno v:
Bone marrow transplantation. 15(1)
The introduction of VP-16 into high-dose therapy regimens used for conditioning before BMT or PBSCT has resulted in higher remission rates and prolonged disease-free survival, even in high risk patients. VP-16 levels have been measured in plasma at t